Topics


Oligodendroglioma | Treatment | Clinical trials | Abemaciclib






Home > Publications > Topics > Oligodendroglioma > Treatment > Clinical trials > Abemaciclib






Wills CA, Mohan S, Nabavizadeh A, Patel T, Prior T, Mansour M, McCoy E, Shah S, Angeloni N, O'Neill M, Frangos S, Blessing C, Coghlan L, Maloney E, Wileyto EP, Desai AS, Bagley SJ.
A single-arm phase 2 study of abemaciclib in adult patients with recurrent grade 3 oligodendroglioma.
Neurooncol Adv. 2025 Jan 17;7(1):vdaf011. doi: 10.1093/noajnl/vdaf011. PMID: 39944054. Interventional study. ˍ